Skip to main content

Adult Endocrinology

  • Chapter
  • First Online:
Genderqueer and Non-Binary Genders

Abstract

This chapter considers the endocrine treatment possibilities for non-binary adults. It discusses the various medicines and interventions which are commonly used and also considers the pros and cons of less commonly used interventions. It also explores the sensitivities necessary when working with this patient group so as to establish good rapport, and the best form of multidisciplinary working for endocrinologists and the wider multidisciplinary team. Lastly, it details the possibilities and limitations of current medicine with regard to effecting non-binary physical changes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Altomare, G., & Capella, G. L. (2002). Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia. The Journal of Dermatology, 29(10), 665–669.

    Article  PubMed  Google Scholar 

  • Anastasiadis, A. G., Davis, A. R., Salomon, L., Burchardt, M., & Shabsigh, R. (2002). Hormonal Factors in Female Sexual Dysfunction. Current Opinion in Urology, 12(6), 503–507. doi:10.1097/01.mou.0000039451.39928.49.

    Article  PubMed  Google Scholar 

  • Anderson, F. D., Feldman, R., & Reape, K. Z. (2008). Endometrial Effects of a 91-day Extended-regimen Oral Contraceptive with Low-Dose Estrogen in Place of Placebo. Contraception, 77(2), 91–96. doi:10.1016/j.contraception.2007.11.006.

    Article  PubMed  Google Scholar 

  • Anderson, F. D., Hait, H., Hsiu, J., Thompson-Graves, A. L., Wilborn, W. H., & Williams, R. F. (2005). Endometrial Microstructure After Long-term Use of a 91-Day Extended-cycle oral Contraceptive Regimen. Contraception, 71(1), 55–59. doi:10.1016/j.contraception.2004.07.013.

    Article  PubMed  Google Scholar 

  • Asscheman, H., Giltay, E. J., Megens, J. A., de Ronde, W. P., van Trotsenburg, M. A., & Gooren, L. J. (2011). A Long-term Follow-Up Study of Mortality in Transsexuals Receiving Treatment with CROSS-sex Hormones. European Journal of Endocrinology, 164(4), 635–642. doi:10.1530/EJE-10-1038.

    Article  PubMed  Google Scholar 

  • Aversa, A., & Morgentaler, A. (2015). The Practical Management of Testosterone Deficiency in men. Nature Reviews Urology, 12(11), 641–650. doi:10.1038/nrurol.2015.238.

    Article  PubMed  Google Scholar 

  • Barth, J. H., Cherry, C. A., Wojnarowska, F., & Dawber, R. P. (1991). Cyproterone Acetate for Severe Hirsutism: Results of a Double-Blind Dose-Ranging Study. Clinical Endocrinology, 35(1), 5–10.

    Article  PubMed  Google Scholar 

  • Baulieu, E. E. (2002). Androgens and Aging Men. Molecular and Cellular Endocrinology, 198(1–2), 41–49.

    Article  PubMed  Google Scholar 

  • Bhasin, S. (2003). Effects of Testosterone Administration on Fat Distribution, Insulin Sensitivity, and Atherosclerosis Progression. Clinical Infectious Diseases, 37(Suppl. 2), S142–S149. doi:10.1086/375878.

    Article  PubMed  Google Scholar 

  • Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., et al. (2005). Older Men are as Responsive as Young Men to the Anabolic Effects Of Graded Doses of Testosterone on the Skeletal Muscle. The Journal of Clinical Endocrinology and Metabolism, 90(2), 678–688. doi:10.1210/jc.2004-1184.

    Article  PubMed  Google Scholar 

  • Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., et al. (2006). Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 91(6), 1995–2010. doi:10.1210/jc.2005-2847.

    Article  PubMed  Google Scholar 

  • Bloch, G. J., & Mills, R. (1995). Prepubertal Testosterone Treatment of Neonatally Gonadectomized Male Rats: Defeminization and Masculinization of Behavioral And Endocrine Function in Adulthood. Neuroscience and Biobehavioral Reviews, 19(2), 187–200.

    Article  PubMed  Google Scholar 

  • Bloch, G. J., Mills, R., & Gale, S. (1995). Prepubertal Testosterone Treatment of Female Rats: Defeminization of Behavioral and Endocrine Function in Adulthood. Neuroscience and Biobehavioral Reviews, 19(2), 177–186.

    Article  PubMed  Google Scholar 

  • Carroll, D. G., & Kelley, K. W. (2009). Use of Antidepressants for Management of Hot Flashes. Pharmacotherapy, 29(11), 1357–1374. doi:10.1592/phco.29.11.1357.

    Article  PubMed  Google Scholar 

  • Ciotta, L., Cianci, A., Calogero, A. E., Palumbo, M. A., Marletta, E., Sciuto, A., et al. (1995). Clinical and Endocrine Effects of Finasteride, a 5 Alpha-reductase Inhibitor, in Women with Idiopathic Hirsutism. Fertility and Sterility, 64(2), 299–306.

    Article  PubMed  Google Scholar 

  • de Roo, C., Tilleman, K., T’Sjoen, G., & de Sutter, P. (2016). Fertility Options in Transgender People. International Review of Psychiatry, 28(1), 112–119.

    Article  PubMed  Google Scholar 

  • Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., et al. (2008). Testosterone for Low Libido in Postmenopausal Women not Taking Estrogen. The New England Journal of Medicine, 359(19), 2005–2017. doi:10.1056/NEJMoa0707302.

    Article  PubMed  Google Scholar 

  • Davis, S. R., & Worsley, R. (2014). Androgen Treatment of Postmenopausal Women. The Journal of Steroid Biochemistry and Molecular Biology, 142, 107–114. doi:10.1016/j.jsbmb.2013.05.006.

    Article  PubMed  Google Scholar 

  • Dhejne, C., Lichtenstein, P., Boman, M., Johansson, A. L., Långström, N., & Landén, M. (2011). Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study In Sweden. PLoS One, 6(2), e16885. doi:10.1371/journal.pone.0016885.

    Article  PubMed  PubMed Central  Google Scholar 

  • Diaz, D. R., Fleming, D. E., & Rhees, R. W. (1995). The Hormone-Sensitive Early Postnatal Periods for Sexual Differentiation of Feminine Behavior and Luteinizing Hormone Secretion in Male and Female Rats. Brain Research. Developmental Brain Research, 86(1–2), 227–232.

    Article  PubMed  Google Scholar 

  • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M. W., & Mueller, A. (2005). Endocrine Treatment of Male-To-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. doi:10.1055/s-2005-865900.

    Article  Google Scholar 

  • Ensrud, K. E., Guthrie, K. A., Hohensee, C., Caan, B., Carpenter, J. S., Freeman, E. W., et al. (2015). Effects of Estradiol and Venlafaxine on Insomnia Symptoms and Sleep Quality in Women with Hot Flashes. Sleep, 38(1), 97–108. doi:10.5665/sleep.4332.

    Article  PubMed  PubMed Central  Google Scholar 

  • Forest, M. G., de Peretti, E., & Bertrand, J. (1980). Testicular and Adrenal Androgens and Their Binding to Plasma Proteins in the Perinatal Period: Developmental Patterns of Plasma Testosterone, 4-androstenedione, Dehydroepiandrosterone and its Sulfate in Premature and Small for Date Infants as Compared with that of Full-Term Infants. Journal of Steroid Biochemistry, 12, 25–36.

    Article  PubMed  Google Scholar 

  • Fraser, I. S. (1990). Treatment of Ovulatory and Anovulatory Dysfunctional Uterine Bleeding with Oral Progestogens. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 30(4), 353–356.

    Article  Google Scholar 

  • Fraser, I. S. (1994). Vaginal Bleeding Patterns in Women Using Once-A-Month Injectable Contraceptives. Contraception, 49(4), 399–420.

    Article  PubMed  Google Scholar 

  • Frey, H., & Aakvaag, A. (1981). The Treatment of Essential Hirsutism in Women with Cyproterone Acetate and Ethinyl Estradiol. Clinical and Endocrine Effects in 10 Cases. Acta Obstetricia et Gynecologica Scandinavica, 60(3), 295–300.

    Article  PubMed  Google Scholar 

  • Futterweit, W. (1998). Endocrine Therapy of Transsexualism and Potential Complications of Long-Term Treatment. Archives of Sexual Behavior, 27(2), 209–226.

    Article  PubMed  Google Scholar 

  • Gambacciani, M., Cappagli, B., Ciaponi, M., Pepe, A., Vacca, F., & Genazzani, A. R. (2008). Ultra Low-Dose Hormone Replacement Therapy and Bone Protection in Postmenopausal Women. Maturitas, 59(1), 2–6. doi:10.1016/j.maturitas.2007.10.007.

    Article  PubMed  Google Scholar 

  • Gambacciani, M., & Ciaponi, M. (2000). Postmenopausal Osteoporosis Management. Current Opinion in Obstetrics & Gynecology, 12(3), 189–197.

    Article  Google Scholar 

  • Gambacciani, M., & Levancini, M. (2014). Hormone Replacement Therapy and the Prevention of Postmenopausal Osteoporosis. Przeglad Menopauzalny, 13(4), 213–220. doi:10.5114/pm.2014.44996.

    PubMed  PubMed Central  Google Scholar 

  • Gambacciani, M., Spinetti, A., de Simone, L., Cappagli, B., Maffei, S., Taponeco, F., et al. (1993). The Relative Contributions Of Menopause and Aging to Postmenopausal Vertebral Osteopenia. The Journal of Clinical Endocrinology and Metabolism, 77(5), 1148–1151. doi:10.1210/jcem.77.5.8077305.

    PubMed  Google Scholar 

  • Garibaldi, L., & Chemaitilly, W. (2011). Physiology of Puberty. In R. Kliegman & W. E. Nelson (Eds.), Nelson Textbook of Pediatrics. (19th ed.) (pp. lxvii, p. 2610). Philadelphia, PA: Elsevier/Saunders.

    Google Scholar 

  • Gast, G. C., Samsioe, G. N., Grobbee, D. E., Nilsson, P. M., & van der Schouw, Y. T. (2010). Vasomotor Symptoms, Estradiol Levels and Cardiovascular Risk Profile in Women. Maturitas, 66(3), 285–290. doi:10.1016/j.maturitas.2010.03.015.

    Article  PubMed  Google Scholar 

  • Gil, M., Oliva, B., Timoner, J., Maciá, M. A., Bryant, V., & de Abajo, F. J. (2011). Risk of Meningioma Among Users of High Doses of Cyproterone Acetate as Compared with the General Population: Evidence from a Population-Based Cohort Study. British Journal of Clinical Pharmacology, 72(6), 965–968. doi:10.1111/j.1365-2125.2011.04031.x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Giltay, E. J., & Gooren, L. J. (2000). Effects of Sex Steroid Deprivation/Administration On Hair Growth and Skin Sebum Production in Transsexual Males and Females. The Journal of Clinical Endocrinology and Metabolism, 85(8), 2913–2921.

    Article  PubMed  Google Scholar 

  • Gooren, L., & Morgentaler, A. (2013). Prostate Cancer Incidence in Orchidectomised Male-To-Female Transsexual Persons Treated with Oestrogens. Andrologia. doi:10.1111/and.12208.

  • Gooren, L. J. (2014). Management of Female-To-Male Transgender Persons: Medical and Surgical Management, Life Expectancy. Current Opinion in Endocrinology, Diabetes, and Obesity, 21(3), 233–238. doi:10.1097/MED.0000000000000064.

    Article  PubMed  Google Scholar 

  • Gooren, L. J., van Trotsenburg, M. A., Giltay, E. J., & van Diest, P. J. (2013). Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment. The Journal of Sexual Medicine, 10(12), 3129–3134. doi:10.1111/jsm.12319.

    Article  PubMed  Google Scholar 

  • Grynberg, M., Fanchin, R., Dubost, G., Colau, J. C., Brémont-Weil, C., Frydman, R., et al. (2010). Histology of Genital Tract and Breast Tissue After Long-Term Testosterone Administration in a Female-To-Male Transsexual Population. Reproductive Biomedicine Online, 20(4), 553–558. doi:10.1016/j.rbmo.2009.12.021.

    Article  PubMed  Google Scholar 

  • Gulmez, S. E., Lassen, A. T., Aalykke, C., Dall, M., Andries, A., Andersen, B. S., et al. (2008). Spironolactone Use and the Risk of Upper Gastrointestinal Bleeding: A Population-Based Case-Control Study. British Journal of Clinical Pharmacology, 66(2), 294–299. doi:10.1111/j.1365-2125.2008.03205.x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hale, G. E., & Shufelt, C. L. (2015). Hormone Therapy in Menopause: An Update on Cardiovascular Disease Considerations. Trends in Cardiovascular Medicine, 25(6), 540–549. doi:10.1016/j.tcm.2015.01.008.

    Article  PubMed  Google Scholar 

  • Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., Spack, N. P., et al. (2009). Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 94(9), 3132–3154. doi:10.1210/jc.2009-0345.

    Article  PubMed  Google Scholar 

  • Hiort, O. (2002). Androgens and Puberty. Best Practice & Research. Clinical Endocrinology & Metabolism, 16(1), 31–41. doi:10.1053/beem.2002.0178.

    Article  Google Scholar 

  • Hutchison, J. B. (1997). Gender-Specific Steroid Metabolism in Neural Differentiation. Cellular and Molecular Neurobiology, 17(6), 603–626.

    Article  PubMed  Google Scholar 

  • Inki, P. (2007). Long-Term Use of the Levonorgestrel-Releasing Intrauterine System. Contraception, 75(Suppl. 6), S161–S166. doi:10.1016/j.contraception.2006.12.016.

    Article  PubMed  Google Scholar 

  • Jacobstein, R., & Polis, C. B. (2014). Progestin-Only Contraception: Injectables and Implants. Best Practice & Research. Clinical Obstetrics & Gynaecology, 28(6), 795–806. doi:10.1016/j.bpobgyn.2014.05.003.

    Article  Google Scholar 

  • Jeppsson, S., Johansson, E. D., Ljungberg, O., & Sjöberg, N. O. (1977). Endometrial Histology and Circulating Levels Of Medroxyprogesterone Acetate (MPA), Estradiol, FSH and LH in Women with MPA Induced Amenorrhoea Compared with Women with Secondary Amenorrhoea. Acta Obstetricia et Gynecologica Scandinavica, 56(1), 43–48.

    Article  PubMed  Google Scholar 

  • Kannel, W. B. (2002). The Framingham Study: Historical Insight on the Impact of Cardiovascular Risk Factors in Men Versus Women. The Journal of Gender-Specific Medicine, 5(2), 27–37.

    PubMed  Google Scholar 

  • Khera, M. (2013). Patients with Testosterone Deficit Syndrome and Depression. Archivos Españoles de Urología, 66(7), 729–736.

    PubMed  Google Scholar 

  • Kwiecien, M., Edelman, A., Nichols, M. D., & Jensen, J. T. (2003). Bleeding Patterns and Patient Acceptability of Standard or Continuous Dosing Regimens of a Low-dose Oral Contraceptive: A Randomized Trial. Contraception, 67(1), 9–13.

    Article  PubMed  Google Scholar 

  • Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., et al. (2008). Body Composition, Volumetric and Areal Bone Parameters in Male-To-Female Transsexual Persons. Bone, 43(6), 1016–1021. doi:10.1016/j.bone.2008.09.001.

    Article  PubMed  Google Scholar 

  • Laufer, L. R., Erlik, Y., Meldrum, D. R., & Judd, H. L. (1982). Effect of Clonidine on Hot Flashes in Postmenopausal Women. Obstetrics and Gynecology, 60(5), 583–586.

    PubMed  Google Scholar 

  • Lee, L. V., & Foody, J. M. (2008). Cardiovascular Disease in Women. Current Atherosclerosis Reports, 10(4), 295–302.

    Article  PubMed  Google Scholar 

  • Light, A. D., Obedin-Maliver, J., Sevelius, J. M., & Kerns, J. L. (2014). Transgender Men Who Experienced Pregnancy After Female-To-Male Gender Transitioning. Obstetrics and Gynecology, 124(6), 1120–1127. doi:10.1097/AOG.0000000000000540.

    Article  PubMed  Google Scholar 

  • Lips, P., van Kesteren, P. J., Asscheman, H., & Gooren, L. J. (1996). The Effect of Androgen Treatment on Bone Metabolism in Female-To-Male Transsexuals. Journal of Bone and Mineral Research, 11(11), 1769–1773. doi:10.1002/jbmr.5650111121.

    Article  PubMed  Google Scholar 

  • Loibl, S., Schwedler, K., von Minckwitz, G., Strohmeier, R., Mehta, K. M., & Kaufmann, M. (2007). Venlafaxine is Superior to Clonidine as Treatment of Hot Flashes in Breast Cancer Patients—A Double-Blind, Randomized Study. Annals of Oncology, 18(4), 689–693. doi:10.1093/annonc/mdl478.

  • Marshall, W. A., & Tanner, J. M. (1969). Variations in Pattern of Pubertal Changes in Girls. Archives of Disease in Childhood, 44(235), 291–303.

    Article  PubMed  PubMed Central  Google Scholar 

  • Marshall, W. A., & Tanner, J. M. (1970). Variations in the Pattern of Pubertal Changes in Boys. Archives of Disease in Childhood, 45(239), 13–23.

    Article  PubMed  PubMed Central  Google Scholar 

  • Marshall, W. A., & Tanner, J. M. (1986). Puberty. In F. Falkner & J. M. Tanner (Eds.), Human Growth: A Comprehensive Treatise (2nd ed., pp. 171–209). New York: Plenum Press.

    Google Scholar 

  • Matsui, S., Yasui, T., Tani, A., Kato, T., Uemura, H., Kuwahara, A., et al. (2014). Effect of Ultra-Low-Dose Estradiol and Dydrogesterone on Arterial Stiffness in Postmenopausal Women. Climacteric, 17(2), 191–196. doi:10.3109/13697137.2013.856399.

    Article  PubMed  Google Scholar 

  • McGreevy, C., & Williams, D. (2011). Safety of Drugs Used in the Treatment of Osteoporosis. Therapeutic Advances in Drug Safety, 2(4), 159–172. doi:10.1177/2042098611411012.

    Article  PubMed  PubMed Central  Google Scholar 

  • Melmed, S., & Williams, R. H. (2011). Williams Textbook of Endocrinology (12th ed.). Philadelphia, PA: Elsevier/Saunders.

    Google Scholar 

  • Meyer, W. J., Finkelstein, J. W., Stuart, C. A., Webb, A., Smith, E. R., Payer, A. F., et al. (1981). Physical and Hormonal Evaluation of Transsexual Patients During Hormonal Therapy. Archives of Sexual Behavior, 10(4), 347–356.

    Article  PubMed  Google Scholar 

  • Meyer, W. J., Webb, A., Stuart, C. A., Finkelstein, J. W., Lawrence, B., & Walker, P. A. (1986). Physical and Hormonal Evaluation of Transsexual Patients: A Longitudinal Study. Archives of Sexual Behavior, 15(2), 121–138.

    Article  PubMed  Google Scholar 

  • Morgan, M. L., Cook, I. A., Rapkin, A. J., & Leuchter, A. F. (2005). Estrogen Augmentation of Antidepressants in Perimenopausal Depression: A Pilot Study. The Journal of Clinical Psychiatry, 66(6), 774–780.

    Article  PubMed  Google Scholar 

  • Mueller, A., & Gooren, L. (2008). Hormone-Related Tumors in Transsexuals Receiving Treatment with Cross-Sex Hormones. European Journal of Endocrinology, 159(3), 197–202. doi:10.1530/EJE-08-0289.

    Article  PubMed  Google Scholar 

  • Mueller, A., Haeberle, L., Zollver, H., Claassen, T., Kronawitter, D., Oppelt, P. G., et al. (2010). Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-To-Male Transsexuals. The Journal of Sexual Medicine, 7(9), 3190–3198. doi:10.1111/j.1743-6109.2010.01912.x.

    Article  PubMed  Google Scholar 

  • Mueller, S. C., Grissom, E. M., & Dohanich, G. P. (2014). Assessing Gonadal Hormone Contributions to Affective Psychopathologies Across Humans and Animal Models. Psychoneuroendocrinology, 46, 114–128. doi:10.1016/j.psyneuen.2014.04.015.

    Article  PubMed  Google Scholar 

  • Neumann, F., & Kalmus, J. (1991). Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience. Experimental and Clinical Endocrinology, 98(2), 71–80. doi:10.1055/s-0029-1211103.

    PubMed  Google Scholar 

  • Nieschlag, E., & Behre, H. M. (2004). Testosterone: Action, Deficiency, Substitution (3rd ed.). Cambridge, UK: Cambridge University Press.

    Google Scholar 

  • Onalan, G., Onalan, R., Selam, B., Akar, M., Gunenc, Z., & Topcuoglu, A. (2005). Mood Scores in Relation to Hormone Replacement Therapies During Menopause: A Prospective Randomized Trial. The Tohoku Journal of Experimental Medicine, 207(3), 223–231.

    Article  PubMed  Google Scholar 

  • Reyes, F. I., Boroditsky, R. S., Winter, J. S., & Faiman, C. (1974). Studies on Human Sexual Development. II. Fetal and Maternal Serum Gonadotropin and Sex Steroid Concentrations. The Journal of Clinical Endocrinology and Metabolism, 38(4), 612–617. doi:10.1210/jcem-38-4-612.

    Article  PubMed  Google Scholar 

  • Rhees, R. W., Kirk, B. A., Sephton, S., & Lephart, E. D. (1997). Effects of Prenatal Testosterone on Sexual Behavior, Reproductive Morphology and LH Secretion in the Female Rat. Developmental Neuroscience, 19(5), 430–437.

    Article  PubMed  Google Scholar 

  • Richards, C., & Seal, L. (2014). Trans People’s Reproductive Options and Outcomes. The Journal of Family Planning and Reproductive Health Care. doi:10.1136/jfprhc-2013-100669.

  • Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., et al. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321-333.

    Google Scholar 

  • Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., .et al. (2007). Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause. JAMA, 297(13), 1465-1477. doi: 10.1001/jama.297.13.1465

  • Ruetsche, A. G., Kneubuehl, R., Birkhaeuser, M. H., & Lippuner, K. (2005). Cortical and Trabecular Bone Mineral Density in Transsexuals After Long-Term Cross-Sex Hormonal Treatment: A Cross-Sectional Study. Osteoporosis International, 16(7), 791–798.

    Article  PubMed  Google Scholar 

  • Saarikoski, S., Yliskoski, M., & Penttilä, I. (1990). Sequential Use of Norethisterone and Natural Progesterone in Pre-menopausal Bleeding Disorders. Maturitas, 12(2), 89–97.

    Article  PubMed  Google Scholar 

  • Salpeter, S. R., Walsh, J. M., Greyber, E., & Salpeter, E. E. (2006). Brief report: Coronary Heart Disease Events Associated with Hormone Therapy in Younger And Older Women. A Meta-Analysis. Journal of General Internal Medicine, 21(4), 363–366. doi:10.1111/j.1525-1497.2006.00389.x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sassarini, J., & Lumsden, M. A. (2015). Oestrogen Replacement in Postmenopausal Women. Age and Ageing, 44(4), 551–558. doi:10.1093/ageing/afv069.

    Article  PubMed  Google Scholar 

  • Seal, L. J. (2007). The Hormonal Management of Adults with Gender Dysphoria. In J. Barrett (Ed.), Transexual and Other Disorders of Gender Identity: A Practical Guide to Management (pp. 157–185). London: Radcliffe.

    Google Scholar 

  • Seal, L. J. (2009). Testosterone Replacement Therapy. Medicine International, 37(9), 445–449.

    Google Scholar 

  • Seal, L. J. (2015). A Review of the Physical and Metabolic Effects of Cross-Sex Hormonal Therapy in the Treatment of Gender Dysphoria. Annals of Clinical Biochemistry. doi:10.1177/0004563215587763.

  • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology and Metabolism, 97(12), 4422–4428. doi:10.1210/jc.2012-2030.

    Article  PubMed  Google Scholar 

  • Simon, L., Kozák, L. R., Simon, V., Czobor, P., Unoka, Z., Szabó, Á., et al. (2013). Regional Grey Matter Structure Differences Between Transsexuals and Healthy Controls—A Voxel Based Morphometry Study. PLoS One, 8(12), e83947. doi:10.1371/journal.pone.0083947.

    Article  PubMed  PubMed Central  Google Scholar 

  • Swaab, D. F., Hofman, M. A., Lucassen, P. J., Purba, J. S., Raadsheer, F. C., & Van de Nes, J. A. (1993). Functional Neuroanatomy and Neuropathology of the Human Hypothalamus. Anatomy and Embryology (Berlin), 187(4), 317–330.

    Article  Google Scholar 

  • Swerdloff, R. S., & Odell, W. D. (1975). Hormonal Mechanisms in the Onset of Puberty. Postgraduate Medical Journal, 51(594), 200–208.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sánchez-Chapado, M., Olmedilla, G., Cabeza, M., Donat, E., & Ruiz, A. (2003). Prevalence of Prostate Cancer and Prostatic Intraepithelial Neoplasia in Caucasian Mediterranean Males: An Autopsy Study. Prostate, 54(3), 238–247. doi:10.1002/pros.10177.

    Article  PubMed  Google Scholar 

  • Tapanainen, J., Kellokumpu-Lehtinen, P., Pelliniemi, L., & Huhtaniemi, I. (1981). Age-Related Changes in Endogenous Steroids of Human Fetal Testis During Early and Midpregnancy. The Journal of Clinical Endocrinology and Metabolism, 52(1), 98–102. doi:10.1210/jcem-52-1-98.

    Article  PubMed  Google Scholar 

  • Tracz, M. J., Sideras, K., Boloña, E. R., Haddad, R. M., Kennedy, C. C., Uraga, M. V., et al. (2006). Testosterone Use in Men and Its Effects on Bone Health. A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. The Journal of Clinical Endocrinology and Metabolism, 91(6), 2011–2016. doi:10.1210/jc.2006-0036.

    Article  PubMed  Google Scholar 

  • Turo, R., Smolski, M., Esler, R., Kujawa, M. L., Bromage, S. J., Oakley, N., et al. (2014). Diethylstilboestrol for the Treatment of Prostate Cancer: Past, Present and Future. Scandinavian Journal of Urology, 48(1), 4–14. doi:10.3109/21681805.2013.861508.

    Article  PubMed  Google Scholar 

  • Van Caenegem, E., Wierckx, K., Taes, Y., Dedecker, D., Van de Peer, F., Toye, K., et al. (2012). Bone Mass, Bone Geometry, and Body Composition in Female-To-Male Transsexual Persons After Long-Term Cross-Sex Hormonal Therapy. The Journal of Clinical Endocrinology and Metabolism, 97(7), 2503–2511. doi:10.1210/jc.2012-1187.

  • Van Goozen, S. H., Cohen-Kettenis, P. T., Gooren, L. J., Frijda, N. H., & Van de Poll, N. E. (1995). Gender Differences in Behaviour: Activating Effects of Cross-Sex Hormones. Psychoneuroendocrinology, 20(4), 343–363.

    Article  PubMed  Google Scholar 

  • van Kesteren, P., Lips, P., Gooren, L. J., Asscheman, H., & Megens, J. (1998). Long-Term Follow-Up of Bone Mineral Density and Bone Metabolism in Transsexuals Treated with Cross-Sex Hormones. Clinical Endocrinology, 48(3), 347–354.

    Article  PubMed  Google Scholar 

  • van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and Morbidity in Transsexual Subjects Treated with Cross-Sex Hormones. Clinical Endocrinology, 47(3), 337–342.

    Article  PubMed  Google Scholar 

  • Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., et al. (2014). Sex Steroid Actions in Male Bone. Endocrine Reviews, 35(6), 906–960. doi:10.1210/er.2014-1024.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang, C., Swerdloff, R. S., Iranmanesh, A., Dobs, A., Snyder, P. J., Cunningham, G., et al. (2000). Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men. The Journal of Clinical Endocrinology and Metabolism, 85(8), 2839–2853.

    Google Scholar 

  • Watts, N. B., Notelovitz, M., Timmons, M. C., Addison, W. A., Wiita, B., & Downey, L. J. (1995). Comparison of Oral Estrogens and Estrogens Plus Androgen on Bone Mineral Density, Menopausal Symptoms, and Lipid-Lipoprotein Profiles in Surgical Menopause. Obstetrics and Gynecology, 85(4), 529–537.

    Article  PubMed  Google Scholar 

  • Wells, G., Tugwell, P., Shea, B., Guyatt, G., Peterson, J., Zytaruk, N., et al. (2002). Meta-Analyses of Therapies for Postmenopausal Osteoporosis. V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women. Endocrine Reviews, 23(4), 529–539. doi:10.1210/er.2001-5002.

    Article  PubMed  Google Scholar 

  • Willemse, P. H., Dikkeschei, L. D., Mulder, N. H., van der Ploeg, E., Sleijfer, D. T., & de Vries, E. G. (1988). Clinical and Endocrine Effects of Cyproterone Acetate in Postmenopausal Patients with Advanced Breast Cancer. European Journal of Cancer & Clinical Oncology, 24(3), 417–421.

    Article  Google Scholar 

  • Winter, J. S., & Faiman, C. (1972). Pituitary-Gonadal Relations in Male Children and Adolescents. Pediatric Research, 6(2), 126–135. doi:10.1203/00006450-197202000-00006.

    Article  PubMed  Google Scholar 

  • World Health Organization Task Force on Methods for the Regulation of Male Fertility. (1990). Contraceptive Efficacy of Testosterone-Induced Azoospermia in Normal Men. Lancet, 336(8721), 955–959.

    Google Scholar 

  • Woods, N. F., & Mitchell, E. S. (2005). Symptoms During the Perimenopause: Prevalence, Severity, Trajectory, and Significance in Women’s Lives. The American Journal of Medicine, 118(Suppl. 12B), 14–24. doi:10.1016/j.amjmed.2005.09.031.

    Article  PubMed  Google Scholar 

  • Zhou, J. N., Hofman, M. A., Gooren, L. J., & Swaab, D. F. (1995). A Sex Difference in the Human Brain and Its Relation to Transsexuality. Nature, 378(6552), 68–70. doi:10.1038/378068a0.

  • Zitzmann, M., Faber, S., & Nieschlag, E. (2006). Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men. The Journal of Clinical Endocrinology & Metabolism, 91(11), 4335–4343. doi:10.1210/jc.2006-0401.

    Article  Google Scholar 

Further Reading

  • Barrett, J. D. (2007). Transsexual and Other Disorders of Gender Identity: A Practical Guide to Management. Abingdon, UK: Radcliffe.

    Google Scholar 

  • Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., Spack, N. P., et al. (2009). Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. doi:10.1210/jc.2009-0345.

  • Melmed, S., & Williams, R. H. (2011). Williams Textbook of Endocrinology (12th ed.). Philadelphia, PA: Elsevier/Saunders.

    Google Scholar 

  • Seal, L. J. (2015). A Review of the Physical and Metabolic Effects of Cross-Sex Hormonal Therapy in the Treatment of Gender Dysphoria. Annals of Clinical Biochemistry. doi:10.1177/0004563215587763.

  • Wylie, K., Barrett, J., Besser, M., Bouman, W., Brain, C., Bridgman, M., et al. (2013). Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria. Retrieved from http://www.rcpsych.ac.uk/files/pdfversion/CR181.pdf

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 2017 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Seal, L. (2017). Adult Endocrinology. In: Richards, C., Bouman, W., Barker, MJ. (eds) Genderqueer and Non-Binary Genders. Critical and Applied Approaches in Sexuality, Gender and Identity. Palgrave Macmillan, London. https://doi.org/10.1057/978-1-137-51053-2_10

Download citation

Publish with us

Policies and ethics